Autor:	W. H. Greb, M. O'Connolly, D. Dierdorf, M.‐E. R. Mayer, D. Wolf
Rok vydání:	1988
Předmět:	Clinical study medicine.medical_specialty business.industry Denbufylline Drug Discovery Physical therapy Medicine Dementia In patient Psychometric testing business medicine.disease
Zdroj:	Drug Development Research. 14:195-198
ISSN:	1098-2299 0272-4391
DOI:	10.1002/ddr.430140307
Popis:	The efficacy and tolerance of denbufylline (25 and 50 mg tid for three months) were investigated in 20 inpatients with cerebrovascular disease in a placebo-controlled, doubleblind parallel study. Denbufylline at 50 mg tid significantly improved the mental, emotional, and social capabilities of the patients; tolerance was acceptable.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7d0aca1ea9e28a3a95697aa3b5c8160f https://doi.org/10.1002/ddr.430140307 Zobrazit plný text záznamu Plný text